🇺🇸 FDA
Pipeline program

LTI-01

LTI-01-2001

Phase 2 small_molecule completed

Quick answer

LTI-01 for Pleural Effusion is a Phase 2 program (small_molecule) at Rein Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Rein Therapeutics
Indication
Pleural Effusion
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials